X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (24) 24
index medicus (23) 23
female (17) 17
male (16) 16
oncology (16) 16
middle aged (14) 14
radiotherapy (13) 13
adult (12) 12
aged (12) 12
cancer (11) 11
chemotherapy (8) 8
disease (8) 8
hodgkin disease - drug therapy (8) 8
hodgkin disease - radiotherapy (8) 8
netherlands (7) 7
antineoplastic combined chemotherapy protocols - therapeutic use (6) 6
care and treatment (6) 6
hodgkin's disease (6) 6
lymphomas (6) 6
procarbazine (6) 6
radiation (6) 6
young adult (6) 6
adolescent (5) 5
combined modality therapy (5) 5
prognosis (5) 5
radiation therapy (5) 5
radiology, nuclear medicine & medical imaging (5) 5
risk factors (5) 5
combined modality treatment (4) 4
doxorubicin - administration & dosage (4) 4
follow-up studies (4) 4
ophthalmology (4) 4
patients (4) 4
procarbazine - administration & dosage (4) 4
radiotherapy dosage (4) 4
survival (4) 4
survivors (4) 4
treatment outcome (4) 4
vincristine - administration & dosage (4) 4
2nd malignancy (3) 3
aged, 80 and over (3) 3
antineoplastic combined chemotherapy protocols - administration & dosage (3) 3
antineoplastic protocols (3) 3
b-cell lymphoma (3) 3
bleomycin - administration & dosage (3) 3
cancer research (3) 3
childhood-cancer (3) 3
choroid - blood supply (3) 3
choroid - radiation effects (3) 3
communication (3) 3
complications and side effects (3) 3
decision making (3) 3
decision-making (3) 3
doctor-patient communication (3) 3
doctor–patient communication (3) 3
dose fractionation (3) 3
doxorubicin (3) 3
fluorescein angiography (3) 3
guidelines (3) 3
hematology (3) 3
hodgkin disease - pathology (3) 3
hodgkin's lymphoma (3) 3
mechlorethamine - administration & dosage (3) 3
medical records (3) 3
medical research (3) 3
medicine, experimental (3) 3
neoplasm staging (3) 3
neoplasms - psychology (3) 3
neoplasms - radiotherapy (3) 3
neoplasms, second primary - epidemiology (3) 3
neovascularization, pathologic - radiotherapy (3) 3
non-hodgkin's lymphomas (3) 3
palliative radiotherapy (3) 3
patient participation (3) 3
physician-patient relations (3) 3
prednisone - administration & dosage (3) 3
radiotherapy - psychology (3) 3
remission induction (3) 3
rias (3) 3
time factors (3) 3
vinblastine (3) 3
vinblastine - administration & dosage (3) 3
6 cycles (2) 2
abridged index medicus (2) 2
advanced stage (2) 2
age (2) 2
alternating chemotherapy (2) 2
analysis system rias (2) 2
antineoplastic agents - adverse effects (2) 2
antineoplastic agents, alkylating - adverse effects (2) 2
bleomycin (2) 2
brain neoplasms - diagnosis (2) 2
brain neoplasms - drug therapy (2) 2
brain neoplasms - radiotherapy (2) 2
breast cancer (2) 2
breast-cancer (2) 2
cancer therapies (2) 2
care (2) 2
case-control studies (2) 2
clinical trials (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 2015, Volume 373, Issue 26, pp. 2499 - 2511
Journal Article
Journal Article
British journal of cancer, ISSN 0007-0920, 2017, Volume 117, Issue 3, pp. 306 - 314
Hodgkin lymphoma (HL) survivors are at increased risk of second malignancies, but few studies have assessed colorectal cancer (CRC) risk after HL treatment. We... 
colorectal cancer | ATOMIC-BOMB SURVIVORS | LONG-TERM RISKS | COLLABORATIVE BRITISH COHORT | chemotherapy | STOMACH-CANCER | procarbazine | second malignant neoplasm | long-term complications | LUNG-CANCER | CHILDHOOD-CANCER | GASTROINTESTINAL CANCER | ONCOLOGY | radiation therapy | DISEASE | 2ND MALIGNANCY | Hodgkin lymphoma | Procarbazine - administration & dosage | Doxorubicin - therapeutic use | Follow-Up Studies | Humans | Middle Aged | Neoplasms, Radiation-Induced - etiology | Netherlands - epidemiology | Male | Antineoplastic Agents - administration & dosage | Vinblastine - therapeutic use | Mechlorethamine - therapeutic use | Young Adult | Hodgkin Disease - radiotherapy | Colorectal Neoplasms - etiology | Bleomycin - therapeutic use | Hodgkin Disease - drug therapy | Adult | Female | Colon | Colorectal Neoplasms - epidemiology | Risk Factors | Survivors | Neoplasms, Second Primary - epidemiology | Neoplasms, Second Primary - etiology | Procarbazine - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Rectum | Vincristine - therapeutic use | Diaphragm | Neoplasms, Radiation-Induced - epidemiology | Prednisone - therapeutic use | Procarbazine | Colorectal carcinoma | Colorectal cancer | Radiation | Health risks | Radiation therapy | Regression analysis | Cancer therapies | Patients | Lymphoma | Incidence | Confidence intervals | Chemotherapy | Colon cancer | Irradiation | Lymphomas | Hodgkin's disease | Cancer | Index Medicus | Clinical Study
Journal Article
B M C Cancer, ISSN 1471-2407, 02/2017, Volume 17, Issue 1, pp. 112 - 112
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2003, Volume 348, Issue 24, pp. 2396 - 2406
Journal Article
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 11/2017, Volume 99, Issue 4, pp. 843 - 853
Young women treated with chest radiation therapy (RT) for Hodgkin lymphoma (HL) experience a strongly increased risk of breast cancer (BC). It is unknown... 
CHILDHOOD-CANCER | ONCOLOGY | DISEASE | REPLACEMENT THERAPY | EARLY MENOPAUSE | ESTROGEN PLUS PROGESTIN | COLLABORATIVE REANALYSIS | YOUNG-WOMEN | SURVIVORS | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | 2ND MALIGNANCY | CHEMOTHERAPY | Confidence Intervals | Humans | Middle Aged | Neoplasms, Radiation-Induced - etiology | Breast Neoplasms - etiology | Hormone Replacement Therapy - adverse effects | Case-Control Studies | Young Adult | Gonadal Steroid Hormones - physiology | Hodgkin Disease - radiotherapy | Menopause, Premature | Netherlands | Time Factors | Antineoplastic Agents - adverse effects | Hodgkin Disease - drug therapy | Adult | Female | Carcinoma, Intraductal, Noninfiltrating - etiology | Breast - radiation effects | Radiotherapy Dosage | Risk Factors | Gonadal Steroid Hormones - pharmacology | Survivors | Ovary - physiology | Antineoplastic Agents, Alkylating - therapeutic use | Procarbazine - adverse effects | Breast - drug effects | Antineoplastic Agents, Alkylating - adverse effects | Dose-Response Relationship, Radiation | Antimitotic agents | Care and treatment | Radiation | Breast cancer | Lymphomas | Plants | Hormones | Radiotherapy | Antineoplastic agents | Health aspects | Risk factors | Cancer | Hormone therapy | Menopause | Oncology, Experimental | Medical records | Mammography | Research | Index Medicus
Journal Article
Cancer and Metastasis Reviews, ISSN 0167-7659, 2011, Volume 30, Issue 2, pp. 153 - 159
Journal Article
International Journal of Radiation Oncology Biology Physics, ISSN 0360-3016, 2007, Volume 67, Issue 1, pp. 19 - 30
PURPOSE: The use of radiotherapy in patients with advanced Hodgkin's lymphoma (HL) is controversial. The purpose of this study was to describe the role of... 
Advanced stage | Combined modality treatment | Radiotherapy | Partial remission | Hodgkin's lymphoma | DISEASE PATIENTS | STAGE | STEM-CELL-TRANSPLANTATION | RANDOMIZED-TRIAL | partial remission | combined modality treatment | ABVD | DETUDES-DES-LYMPHOMES | advanced stage | POSITRON-EMISSION-TOMOGRAPHY | ONCOLOGY | radiotherapy | HIGH-DOSE CHEMOTHERAPY | STANFORD-V | LADULTE H89 TRIAL | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Procarbazine - administration & dosage | Hodgkin Disease - pathology | Humans | Middle Aged | Male | Mediastinal Neoplasms - mortality | Vinblastine - administration & dosage | Hodgkin Disease - radiotherapy | Mediastinal Neoplasms - drug therapy | Hodgkin Disease - drug therapy | Hodgkin Disease - mortality | Vincristine - administration & dosage | Adult | Female | Doxorubicin - administration & dosage | Prednisone - administration & dosage | Logistic Models | Survival Rate | Combined Modality Therapy | Bleomycin - administration & dosage | Remission Induction | Neoplasms, Second Primary - etiology | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Mediastinal Neoplasms - radiotherapy | Adolescent | Aged | Mechlorethamine - administration & dosage | Chemotherapy | Lymphomas | Cancer | Hybrids | Mechlorethamine | Vinblastine | Clinical trials | Malignancy | Prednisone | Doxorubicin | Survival | Vincristine | procarbazine | Remission | Hodgkin's disease | Index Medicus | LYMPHOMAS | PATIENTS | PREDNISONE | DOXORUBICIN | RADIOLOGY AND NUCLEAR MEDICINE | VINBLASTINE | RADIOTHERAPY | CHEMOTHERAPY
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2015, Volume 373, Issue 26, pp. 2499 - 2511
Despite efforts to reduce the incidence of second cancer, the risk was not lower among 5-year survivors of Hodgkin's lymphoma in the Netherlands treated... 
Procarbazine | Chemotherapy | Menopause | Lymphomas | Breast cancer | Radiation therapy | Health risk assessment | Lymphoma | Cancer therapies | Patients | Age | Cancer | Population | Trends | Tumors
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 05/2014, Volume 32, Issue 15, pp. 9517 - 9517
Conference Proceeding